Methods of performing brachytherapy
In one aspect, radioactive nanoparticles are described herein. In some embodiments, a radioactive nanoparticle described herein comprises a metal nanoparticle core, an outer metal shell disposed over the metal nanoparticle core, and a metallic radioisotope disposed within the metal nanoparticle core or within the outer metal shell. In some cases, the radioactive nanoparticle has a size of about 30-500 nm in three dimensions. In addition, in some embodiments, the radioactive nanoparticle further comprises an inner metal shell disposed between the metal nanoparticle core and the outer metal shell. The metal nanoparticle core, outer metal shell, and inner metal shell of the radioactive nanoparticle can have various metallic compositions.
1. A method of performing brachytherapy, the method comprising:
disposing a composition within a biological compartment,
wherein the composition comprises a plurality of radioactive nanoparticles, at least one of the plurality of radioactive nanoparticles comprising:
a metal nanoparticle core;
an outer metal shell disposed over the metal nanoparticle core; and
a metallic radioisotope disposed within the metal nanoparticle core or within the outer metal shell,
wherein the radioactive nanoparticle has a size of 30-500 nm in three dimensions, and
wherein the at least one radioactive nanoparticle has a radioactivity of 0.4 to 400 Bq.
2. The method of claim 1 , wherein the metallic radioisotope is a β-emitter.
3. The method of claim 1 , wherein the biological compartment is a tumor.
4. The method of claim 3 , wherein at least 80% of the radioactive nanoparticles are retained within the tumor for at least 3 weeks.
5. The method of claim 1 further comprising:
irradiating the biological compartment with an external beam of ionizing radiation.
6. The method of claim 1 , wherein the composition is a colloidal dispersion of the plurality of radioactive nanoparticles.
7. The method of claim 1 , wherein disposing the composition in the biological compartment comprises injecting the composition into the biological compartment.
8. The method of claim 1 , wherein the biological compartment is a tumor and the composition is injected into the tumor or into a region within 5 cm of the tumor.
9. The method of claim 1 , wherein the composition is injected into a blood vessel associated with the biological compartment.
10. The method of claim 1 , wherein the composition is injected as part of a transarterial infusion treatment.
11. The method of claim 8 , wherein the tumor is unresectable.
12. The method of claim 8 , wherein the tumor has a size of 5 cm or less.
13. The method of claim 1 , wherein the composition is injected as an intraarterial infusion.
14. The method of claim 1 , wherein the biological compartment is a site from which a tumor or other diseased tissue was previously removed.
15. The method of claim 1 , the method further comprising:
exposing the biological compartment in which the radioactive nanoparticles are disposed to a beam of electromagnetic radiation having a wavelength that can be absorbed by the radioactive nanoparticles.
16. The method of claim 1 , wherein:
the radioactive nanoparticle further comprises an inner metal shell disposed between the metal nanoparticle core and the outer metal shell; and
the inner metal shell is formed from a metal having a lower reduction potential than a metal of the outer metal shell.
17. The method of claim 1 , wherein:
the radioactive nanoparticle further comprises an inner metal shell disposed between the metal nanoparticle core and the outer metal shell;
the metal nanoparticle core is formed from Au;
the inner metal shell is formed from Cu;
the outer metal shell is formed from Pd, Rh, or Au; and
radiation emitted by the metallic radioisotope passes through the inner metal shell and/or the outer metal shell into the biological compartment without heating the inner metal shell and/or the outer metal shell.